Selected
Publications
Bennett V, Healy J. (2008) Being there: cellular targeting of voltage-gated sodium channels in the heart. J Cell Biol. 180(1):13-5. -PDF-
Bennett V, Healy J. (2008) Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin. Trends Mol Med. 14(1):28-36. -PDF-
Abdi KM, Bennett V. (2008) Adducin Promotes Micrometer-Scale Organization of {beta}2-Spectrin in Lateral Membranes of Bronchial Epithelial Cells. Mol Biol Cell 19(2):536-45. -PDF-
Mohler PJ, Healy JA, Xue H, Puca AA, Kline CF, Allingham RR, Kranias EG, Rockman HA, Bennett V. Ankyrin-B syndrome: enhanced cardiac function balanced by risk of cardiac death and premature senescence. (2007) PLoS ONE. 2(10):e1051. -PDF-
Kizhatil K, Davis JQ, Davis L, Hoffman J, Hogan BL, Bennett V. (2007) Ankyrin-G is a molecular partner of E-cadherin in epithelial cells and early embryos. J Biol Chem. 282(36):26552-61. -PDF-
Kizhatil K, Yoon W, Mohler PJ, Davis LH, Hoffman JA, Bennett V. (2007) Ankyrin-G and beta2-spectrin collaborate in biogenesis of lateral membrane of human bronchial epithelial cells. J Biol Chem. 282(3):2029-37. -PDF-
Lee G, Abdi K, Jiang Y, Michaely P, Bennett
V, Marszalek PE. (2006) Nanospring behaviour of ankyrin
repeats. Nature.440:246-9. -PDF-
Abdi
KM, Mohler PJ, Davis JQ, Bennett V. (2006) Isoform
specificity of ankyrin-B: a site in the divergent C-terminal domain
is required for intramolecular association. J
Biol Chem. 281:5741-9. -PDF-
Pan
Z, Kao T, Horvath Z, Lemos J, Sul JY, Cranstoun SD,
Bennett V, Scherer SS, Cooper EC. (2006) A common
ankyrin-G-based mechanism retains KCNQ and NaV channels
at electrically active domains of the axon. J Neurosci.
26:2599-613. -PDF-
Mohler, PJ, Davis, JQ, Bennett, V. (2005) Ankyrin-B
coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3
receptor in a specialized microdomain of cardiac T-tubules.
Plos Biology 3:e423. -PDF-
Mohler, P.J., Splawski, I., Napolitano, C., Botteli,
G., Sharpe, L., Timothy, K.,
Priori, S.G., Keatiing, M.T., and Bennett, V. (2004)
A cardiac arrhythmia syndrome caused by loss of ankyrin-B
function. Proc. Nat. Acad. Sci. USA.
101:9137-42. -PDF-
Mohler
PJ, Rivolta I, Napolitano C, LeMaillet G, Lambert
S, Priori SG, Bennett V. (2004) Nav1.5
E1053K mutation causing Brugada syndrome blocks binding
to ankyrin-G and expression of Nav1.5 on the surface
of cardiomyocytes. Proc
Natl Acad Sci USA. 101:17533-8. -PDF-
Mohler, P. J et al. (2003) Ankyrin-B mutation causes
type 4 long QT cardiac arrhythmia and sudden cardiac
death. Nature 421:634-639. -PDF-
|
Future
Directions
Our current research is addressing three general questions: 1. Physiological roles of ankyrins. We are currently exploring ankyrin function in insulin release by pancreatic beta cells, targeting components of the dystrophin complex in striated muscle, and in establishing membrane domains in photoreceptors in the retina. 2. Cellular mechanisms underlying ankyrin-dependent protein localization. One experimental model for these studies is human bronchial epithelial cells where ankyrin-G and beta-2 spectrin are required for biogenesis of the lateral membrane. We also will develop adult cardiomyocytes as an experimental system. We plan to elucidate the ankyrin/spectrin pathways in cardiomyocytes and epithelial cells using a variety of techniques including proteomics, live cell imaging, and siRNA knockdowns. 3. Role of ankyrin-B in aging-related diseases in humans and mice. We have found that ankyrin-B (+/-) mice have reduced life-span and exhibit accelerated senescence in multiple tissues. We also have found that loss-of-function mutations in ankyrin-B are surprisingly common in human populations (2 percent of Europeans). Our working model is that these human ankyrin-B mutations represent balanced polymorphisms with benefits (increased cardiac performance) balanced by costs (risk of sudden cardiac death and reduced life span). At a clinical level, we are exploring roles of ankyrin-B in aging-related diseases including diabetes and atherosclerosis. In addition, we are developing mouse models with knock-in of two of the human ankyrin-B variants. We also are exploring the hypothesis that ankyrin-B-dependent aging is due to stem cell exhaustion. |